β-Agonists and asthma: too much of a good thing?
In an unusual paradox, asthmatics who are chronically treated with bronchodilating β-agonists sometimes experience a worsening of their condition. A new study describes one possible mechanism and reveals a potential new therapeutic target in the treatment of asthma.
Enregistré dans:
| Publié dans: | J Clin Invest |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171402/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12925688/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19642 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|